-
Mashup Score: 12Post-Doc Research Associate - 4 month(s) ago
Purpose of the position is to perform molecular biology and computational biology/bioinformatic analysis. The lab focuses on the genetic and epigenetic changes that occur during bladder and renal cancer development. The Research Associate will perform genetic manipulation of genes within model systems including cell lines, organoids, mouse models and assess the phenotypes including alterations in signal transduction pathways, transcriptome changes, and synthetic lethality.
Source: unc.peopleadmin.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16A new era in the treatment of urothelial carcinoma - 7 month(s) ago
The advances in targeted therapies, immunotherapy, and the recent emergence of antibody-drug conjugates (ADCs) herald a potential paradigm shift in tr…
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists1Tweet-
RT @FaltasLab: 📘 Honored to guest edit this @UrolOncol Special Issue on advances in UC treatments ➡️ https://t.co/boHwK4MIaV Featuring arti…
-
-
Mashup Score: 13The Best Hospitals for Urology - 9 month(s) ago
Learn which hospitals were ranked best by US News & World Report for urology. Scores factor in patient safety, nurse staffing and more.
Source: health.usnews.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @UrologyMSK: 🥇Very exciting day for our Urology team led @easthamja 🥇!!! https://t.co/hjTtUoDaKJ
-
-
Mashup Score: 1REP. CARTWRIGHT INTRODUCES BIPARTISAN RESOLUTION TO INCREASE BLADDER CANCER AWARENESS - 12 month(s) ago
U.S. Representative Matt Cartwright (PA-08) re-introduced a bipartisan resolution to designate May as National Bladder Cancer Awareness Month. In 2023 alone, an estimated 82,290 individuals in the United States will be diagnosed with bladder cancer and nearly 17,000 will die due to the disease. “In the fight against cancer, increasing early detection is paramount,” said Rep. Cartwright. “This…
Source: Congressman Matt CartwrightCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @bcan_chisolm: @BladderCancerUS thanks @RepCartwright for raising national awareness about #bladdercancer today! https://t.co/OmJZLiBQ7N
-
-
Mashup Score: 5Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline - American Urological Association - 1 year(s) ago
The purpose of this guideline is to provide a useful reference on the effective evidence-based diagnoses and management of non-metastatic upper tract urothelial carcinoma (UTUC).
Source: www.auanet.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @CChuMD: New 2023 SUO/AUA guidelines for UTUC: https://t.co/qNN1corEsV 🔬Universal histologic assessment 👨👩👧👦Screening for Lynch synd…
-
-
Mashup Score: 1Memorial Sloan Kettering Cancer Center Careers - 1 year(s) ago
Let’s change the way the world treats cancer Our multi-disciplinary teams work together to provide exceptional patient care, develop innovative research, and deliver outstanding educational programs.
Categories: Hem/Oncs, Latest HeadlinesTweet-
RT @JVJAI: We are hiring a Bioinformatician to work on NGS, GWAS data in NYC. More info below. https://t.co/4U8ValFjln
-
-
Mashup Score: 7
Clinton et al. define the concordance of genomic alterations in urothelial carcinoma from a localized to metastatic state to identify drivers of progression. Within individual patients, there is significant discordance between primary and metastatic sites. Additionally, plasma cell-free DNA (cfDNA) can identify alterations not detected by tumor sequencing.
Source: Cell ReportsCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @CellReports: Genomic heterogeneity as a barrier to precision oncology in urothelial cancer https://t.co/4rcfRMfcxk
-
-
Mashup Score: 10Faltas Lab | Weill Cornell Medicine - 2 year(s) ago
The Faltas Lab focuses on studying bladder cancer as a model disease for dissecting the fundamental biological mechanisms that drive the evolution of human cancers.
Source: faltaslab.weill.cornell.eduCategories: Latest Headlines, Oncologists1Tweet-
RT @FaltasLab: 🚨Job alert #postbac #labtech #jobs. My lab https://t.co/HRIpAU7aLd is hiring a technician & lab manager to work on synthetic…
-
-
Mashup Score: 22Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer - 2 year(s) ago
Abstract. Purpose: Identification of inherited germline variants can guide personalized cancer screening, prevention, and treatment. Pathogenic and likely pathogenic (P/LP) germline variants in cancer predisposition genes are frequent among patients with locally advanced or metastatic urothelial carcinoma, but their prevalence and significance in patients with non-muscle invasive bladder cancer…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Just in time for #BCANTT22, our initial look at pathogenic/likely pathogenic germline variants in patients with early stage #bladdercancer #NMIBC now out in @CCR_AACR Supported by YIA from @BladderCancerUS among others @UrologyMSK 1/n https://t.co/9dABVglFw5
-
-
Mashup Score: 5
Intravesical immunotherapy with Bacillus Calmette-Guérin (BCG) has been the standard of care for patients with high-risk non non–muscle invasive bladd…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Outstanding review on immunotherapy in NMIBC #bladdercancer by star @SUO_YUO fellow @CChuMD @UrologyMSK @MSKCancerCenter @BladderCancerUS A few take-homes and thoughts: 1/n https://t.co/P2E7ntpExa
-
RT @WilliamKimMD: Post-doc position open with a focus on assay development for drug discovery! PLEASE APPLY👇 https://t.co/IClt2iiRcV #Tea…